Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2023-07-20 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Dividend/Other business matters
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the unaudited financial results for the quarter ended June 30, 2023, and to consider the proposal of declaration of an interim dividend. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about board meetings. The document does not contain any financial data or results itself but is an announcement of an upcoming meeting where such results will be approved. The document length is short (1939 characters), and it is clearly a notice rather than a report or financial statement. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement rather than an Interim Report (IR) or Earnings Release (ER).
2023-07-20 English
Allotment of Securities
Share Issue/Capital Change Classification · 95% confidence The document is a short notice informing the stock exchanges about the allotment of equity shares under the Employee Stock Option Plan (ESOP) 2010. It mentions the increase in paid-up equity share capital due to this allotment. The document is dated July 13, 2023, and is addressed to the National Stock Exchange of India and BSE Limited. It does not contain financial statements, detailed analysis, or comprehensive report content. It is an announcement of a capital change (allotment of shares) rather than a full report or detailed filing. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is only 1487 characters, which is short and typical for such announcements.
2023-07-13 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2023. It includes a certificate from the Registrar & Share Transfer Agent confirming compliance. The document is short (1443 characters) and serves as a regulatory compliance update rather than a financial report or detailed filing. It does not contain financial statements or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents.
2023-07-06 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs about the trading window closure period around the announcement of financial results for the quarter ending June 30, 2023. The document is short (1600 characters) and serves as an announcement related to insider trading compliance rather than a financial report or detailed filing. It does not contain financial data, management discussion, or any report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance-related notices that do not fit other specific categories.
2023-06-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2040 characters) informing about the schedule of analyst and institutional investor meetings, including conference calls and roadshows. It is an intimation pursuant to SEBI regulations and does not contain any financial data, results, or detailed reports. It is not a full report, earnings release, or management discussion. The document serves as a regulatory announcement about upcoming investor interactions. According to the rules, such announcements fall under Regulatory Filings (RNS) as they do not contain substantive financial information or constitute a report themselves.
2023-06-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of upcoming investor meetings and does not contain financial data, report content, or detailed presentations. The document length is short (1948 characters) and serves as an intimation rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-26 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.